ECT2L
gene geneOn this page
Also known as ARHGEF32FBXO49LFDH
Summary
ECT2L (epithelial cell transforming 2 like, HGNC:21118) is a protein-coding gene on chromosome 6q24.1, encoding Epithelial cell-transforming sequence 2 oncogene-like (Q008S8). May act as a guanine nucleotide exchange factor (GEF).
Predicted to enable guanyl-nucleotide exchange factor activity.
Source: NCBI Gene 345930 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 165 total
- GTEx eGene: eQTL in 26 tissues, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.13 (unconstrained)
- MANE Select transcript:
NM_001077706 - Notable: 165 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21118 |
| Approved symbol | ECT2L |
| Name | epithelial cell transforming 2 like |
| Location | 6q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ARHGEF32, FBXO49, LFDH |
| Ensembl gene | ENSG00000203734 |
| Ensembl biotype | protein_coding |
| Entrez | 345930 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
MANE Select: ENST00000541398
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 3: 1, TSL 4: 1, TSL 5: 2
ENST00000541398, ENST00000367682, ENST00000401414, ENST00000495970, ENST00001139043
RefSeq mRNA: 2 — MANE Select: NM_001077706
NM_001077706, NM_001195037
CCDS: CCDS43508
Canonical transcript exons
ENST00000541398 — 22 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001445363 | 138849269 | 138849434 |
| ENSE00001445364 | 138842979 | 138843231 |
| ENSE00001445368 | 138813172 | 138813340 |
| ENSE00001531504 | 138902500 | 138904070 |
| ENSE00001531506 | 138900948 | 138901120 |
| ENSE00001531511 | 138888943 | 138889031 |
| ENSE00001531513 | 138886857 | 138886922 |
| ENSE00001531516 | 138885674 | 138885830 |
| ENSE00001531519 | 138885506 | 138885579 |
| ENSE00001531522 | 138882724 | 138882871 |
| ENSE00001531525 | 138880957 | 138881171 |
| ENSE00001531528 | 138876472 | 138876558 |
| ENSE00001531550 | 138846539 | 138846677 |
| ENSE00001531553 | 138844412 | 138844580 |
| ENSE00001547299 | 138812838 | 138812977 |
| ENSE00001747099 | 138814491 | 138814603 |
| ENSE00003500465 | 138862627 | 138862719 |
| ENSE00003520793 | 138868103 | 138868206 |
| ENSE00003630928 | 138864996 | 138865178 |
| ENSE00003632506 | 138854026 | 138854154 |
| ENSE00003704874 | 138796087 | 138796192 |
| ENSE00003716460 | 138838352 | 138838514 |
Expression profiles
Bgee: expression breadth ubiquitous, 125 present calls, max score 88.88.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1382 / max 34.8197, expressed in 48 samples.
Highest expression (Bgee): uterine tube, olfactory segment of nasal mucosa, fallopian tube, heart left ventricle, lung.
Genetic regulation across tissues (GTEx eQTL / sQTL)
ECT2L is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 26 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 26 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Nerve Tibial | eqtl | 3.0e-50 | -0.65 | 6:138796035:G:A |
| Skin Sun Exposed Lower leg | eqtl | 2.7e-15 | +0.43 | 6:138794160:G:GATCT |
| Adipose Subcutaneous | eqtl | 2.5e-13 | +0.41 | 6:138794160:G:GATCT |
| Heart Left Ventricle | eqtl | 4.5e-12 | -0.40 | 6:138871605:A:G |
| Pituitary | eqtl | 6.4e-12 | -0.51 | 6:138909207:G:A |
| Esophagus Mucosa | eqtl | 7.0e-12 | -0.44 | 6:138893682:G:A |
| Heart Atrial Appendage | eqtl | 3.1e-11 | -0.46 | 6:138867558:C:T |
| Testis | eqtl | 2.8e-10 | +0.34 | 6:138789208:A:G |
| Esophagus Muscularis | eqtl | 2.5e-09 | -0.36 | 6:138796035:G:A |
| Artery Tibial | eqtl | 1.6e-08 | +0.37 | 6:138792499:GA:G |
| Adipose Visceral Omentum | eqtl | 2.5e-07 | +0.42 | 6:138794160:G:GATCT |
| Colon Sigmoid | eqtl | 1.1e-06 | -0.44 | 6:138793829:C:T |
| Breast Mammary Tissue | eqtl | 1.2e-05 | +0.30 | 6:138789208:A:G |
| Skin Not Sun Exposed Suprapubic | eqtl | 1.4e-05 | +0.28 | 6:138794160:G:GATCT |
| Adrenal Gland | eqtl | 1.4e-05 | +0.58 | 6:138784382:A:G |
| Colon Transverse | eqtl | 1.5e-04 | -0.34 | 6:138786059:A:G |
| Small Intestine Terminal Ileum | eqtl | 3.3e-04 | +0.49 | 6:138971546:A:G |
| Brain Cerebellar Hemisphere | eqtl | 6.5e-04 | +0.34 | 6:138971546:A:G |
| Thyroid | eqtl | 9.8e-04 | -0.24 | 6:138886773:C:T |
| Cells Cultured fibroblasts | eqtl | 2.8e-03 | -0.28 | 6:138793829:C:T |
FANTOM5 promoters
3 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 70124 | 0.0608 | 23 |
| 70123 | 0.0598 | 25 |
| 70125 | 0.0175 | 7 |
Top tissues by expression
showing 100 of 128 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 88.88 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.62 | gold quality |
| fallopian tube | UBERON:0003889 | 70.13 | gold quality |
| heart left ventricle | UBERON:0002084 | 62.61 | gold quality |
| right lung | UBERON:0002167 | 61.51 | gold quality |
| calcaneal tendon | UBERON:0003701 | 60.38 | gold quality |
| pituitary gland | UBERON:0000007 | 60.05 | gold quality |
| heart | UBERON:0000948 | 59.76 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 59.42 | silver quality |
| right atrium auricular region | UBERON:0006631 | 59.12 | gold quality |
| adenohypophysis | UBERON:0002196 | 57.22 | gold quality |
| endometrium | UBERON:0001295 | 56.72 | gold quality |
| ventricular zone | UBERON:0003053 | 56.49 | gold quality |
| lung | UBERON:0002048 | 56.25 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 54.93 | gold quality |
| cerebellar cortex | UBERON:0002129 | 54.89 | gold quality |
| cerebellum | UBERON:0002037 | 54.72 | gold quality |
| bone marrow cell | CL:0002092 | 54.68 | gold quality |
| Ammon’s horn | UBERON:0001954 | 54.44 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 53.89 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 53.72 | gold quality |
| corpus callosum | UBERON:0002336 | 53.71 | gold quality |
| mucosa of stomach | UBERON:0001199 | 53.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 53.43 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 52.72 | gold quality |
| hypothalamus | UBERON:0001898 | 52.59 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 52.18 | gold quality |
| granulocyte | CL:0000094 | 51.97 | gold quality |
| caudate nucleus | UBERON:0001873 | 51.82 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 51.80 | gold quality |
| brain | UBERON:0000955 | 51.76 | gold quality |
| bone marrow | UBERON:0002371 | 51.57 | silver quality |
| endocervix | UBERON:0000458 | 51.56 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 51.36 | gold quality |
| skin of leg | UBERON:0001511 | 51.25 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 51.11 | gold quality |
| zone of skin | UBERON:0000014 | 50.97 | gold quality |
| amygdala | UBERON:0001876 | 50.91 | gold quality |
| temporal lobe | UBERON:0001871 | 50.89 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 50.83 | gold quality |
| minor salivary gland | UBERON:0001830 | 50.59 | gold quality |
| leukocyte | CL:0000738 | 50.49 | silver quality |
| apex of heart | UBERON:0002098 | 50.44 | gold quality |
| myometrium | UBERON:0001296 | 50.38 | gold quality |
| skin of abdomen | UBERON:0001416 | 50.36 | gold quality |
| cerebral cortex | UBERON:0000956 | 50.33 | gold quality |
| nucleus accumbens | UBERON:0001882 | 50.31 | gold quality |
| muscle tissue | UBERON:0002385 | 50.31 | gold quality |
| monocyte | CL:0000576 | 49.88 | silver quality |
| lower esophagus muscularis layer | UBERON:0035833 | 49.70 | gold quality |
| lower esophagus | UBERON:0013473 | 49.64 | gold quality |
| body of uterus | UBERON:0009853 | 49.41 | gold quality |
| right frontal lobe | UBERON:0002810 | 49.30 | gold quality |
| urinary bladder | UBERON:0001255 | 49.27 | gold quality |
| uterine cervix | UBERON:0000002 | 49.09 | gold quality |
| duodenum | UBERON:0002114 | 49.03 | gold quality |
| primary visual cortex | UBERON:0002436 | 48.95 | silver quality |
| substantia nigra | UBERON:0002038 | 48.90 | gold quality |
| colonic epithelium | UBERON:0000397 | 48.77 | gold quality |
| left uterine tube | UBERON:0001303 | 48.74 | gold quality |
| liver | UBERON:0002107 | 48.56 | silver quality |
| multicellular organism | UBERON:0000468 | 48.34 | gold quality |
| muscle of leg | UBERON:0001383 | 48.23 | silver quality |
| blood | UBERON:0000178 | 48.10 | gold quality |
| tibial nerve | UBERON:0001323 | 48.05 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 47.90 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 47.78 | gold quality |
| esophagus | UBERON:0001043 | 47.65 | gold quality |
| frontal cortex | UBERON:0001870 | 47.60 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 47.51 | gold quality |
| right lobe of liver | UBERON:0001114 | 47.35 | gold quality |
| gall bladder | UBERON:0002110 | 47.07 | gold quality |
| putamen | UBERON:0001874 | 46.98 | gold quality |
| islet of Langerhans | UBERON:0000006 | 46.73 | gold quality |
| prefrontal cortex | UBERON:0000451 | 46.63 | gold quality |
| gastrocnemius | UBERON:0001388 | 46.55 | silver quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 46.38 | gold quality |
| tibial artery | UBERON:0007610 | 46.16 | gold quality |
| popliteal artery | UBERON:0002250 | 46.12 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 46.11 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 46.10 | silver quality |
| lymph node | UBERON:0000029 | 46.08 | gold quality |
| adrenal tissue | UBERON:0018303 | 46.04 | gold quality |
| prostate gland | UBERON:0002367 | 45.97 | gold quality |
| fundus of stomach | UBERON:0001160 | 45.79 | gold quality |
| vagina | UBERON:0000996 | 45.77 | gold quality |
| esophagus mucosa | UBERON:0002469 | 45.60 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 45.33 | gold quality |
| testis | UBERON:0000473 | 45.18 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 45.06 | gold quality |
| stomach | UBERON:0000945 | 44.91 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 44.87 | gold quality |
| adrenal gland | UBERON:0002369 | 44.84 | gold quality |
| right coronary artery | UBERON:0001625 | 44.66 | gold quality |
| thyroid gland | UBERON:0002046 | 44.64 | gold quality |
| colon | UBERON:0001155 | 44.51 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 44.47 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 44.44 | silver quality |
| intestine | UBERON:0000160 | 44.26 | gold quality |
| body of stomach | UBERON:0001161 | 44.21 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.13 |
HPA expression
RNA tissue specificity: Tissue enriched
57 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Fallopian tube | tissue | 8.1 |
| Choroid plexus | tissue | 6.2 |
| Periaqueductal gray | tissue | 4.4 |
| Hippocampus | tissue | 3.5 |
| Postcentral gyrus | tissue | 2.6 |
| Locus coeruleus | tissue | 2.4 |
| Basal ganglia | tissue | 2.1 |
| Nucleus accumbens | tissue | 2.0 |
| Hypothalamus | tissue | 1.6 |
| Heart muscle | tissue | 1.5 |
| Hippocampal formation | tissue | 1.5 |
| Septum | tissue | 1.5 |
| Lung | tissue | 1.4 |
| Pons | tissue | 1.3 |
| Medulla oblongata | tissue | 1.0 |
| Amygdala | tissue | 0.9 |
| Thalamus | tissue | 0.9 |
| Corpus callosum | tissue | 0.9 |
| Midbrain | tissue | 0.8 |
| Ventral forebrain | tissue | 0.8 |
| Superior colliculi | tissue | 0.6 |
| Spinal cord | tissue | 0.6 |
| Cerebral cortex | tissue | 0.5 |
| Putamen | tissue | 0.5 |
| Substantia nigra | tissue | 0.5 |
| Olfactory bulb | tissue | 0.5 |
| Retrosplenial cortex | tissue | 0.5 |
| Cervix | tissue | 0.4 |
| Skin 1 | tissue | 0.4 |
| Prefrontal cortex | tissue | 0.4 |
| Retina | tissue | 0.4 |
| Motor cortex | tissue | 0.4 |
| Cerebellum | tissue | 0.4 |
| Entorhinal cortex | tissue | 0.4 |
| Retrosplenial and cingulate cortex | tissue | 0.4 |
| Insular cortex | tissue | 0.4 |
| Breast | tissue | 0.3 |
| Testis | tissue | 0.3 |
| Urinary bladder | tissue | 0.3 |
| Adrenal gland | tissue | 0.3 |
| Bone marrow | tissue | 0.3 |
| Somatosensory cortex | tissue | 0.3 |
| Temporal cortex | tissue | 0.3 |
| Occipital cortex | tissue | 0.3 |
| Pituitary gland | tissue | 0.2 |
| Salivary gland | tissue | 0.2 |
| Skeletal muscle | tissue | 0.2 |
| Endometrium 1 | tissue | 0.2 |
| Lymph node | tissue | 0.1 |
| Stomach 1 | tissue | 0.1 |
| Vagina | tissue | 0.1 |
| Smooth muscle | tissue | 0.1 |
| Thyroid gland | tissue | 0.1 |
| Spleen | tissue | 0.1 |
| Prostate | tissue | 0.1 |
| Caudate putamen | tissue | 0.1 |
| Appendix | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 188; highest nTPM — Nucleus tractus solitarii (6.7), Periaquaductal grey, lateral (5.9), Hippocampus, CA1 (5.3), Cervical spinal cord, central gray (5.2), Corticomedial amygdala (5.0).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting ECT2L by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 62 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
Functional genomics
gnomAD constraint: pLI 6.69e-35, LOEUF 1.13, missense Z 0.996 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000541398 — one region, missense o/e 0.95.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ect2l | ENSDARG00000091471 |
| mus_musculus | Ect2l | ENSMUSG00000071392 |
| rattus_norvegicus | Ect2l | ENSRNOG00000055142 |
| caenorhabditis_elegans | WBGENE00001366 | |
| caenorhabditis_elegans | WBGENE00001490 |
Paralogs (10): FARP2 (ENSG00000006607), FGD1 (ENSG00000102302), FGD3 (ENSG00000127084), ARHGEF39 (ENSG00000137135), FGD4 (ENSG00000139132), FGD2 (ENSG00000146192), FARP1 (ENSG00000152767), FGD5 (ENSG00000154783), FRMD7 (ENSG00000165694), FGD6 (ENSG00000180263)
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Aspergillus fumigatus A1163 | B0XTS1 | 100.0% | Diamond |
| Aspergillus fumigatus Af293 | Q4X0A9 | 100.0% | Diamond |
| Trichophyton benhamiae CBS 112371 | D4AM37 | 99.5% | Diamond |
| Trichophyton verrucosum HKI 0517 | D4D8P3 | 99.5% | Diamond |
| Aspergillus flavus NRRL3357 | B8NGT5 | 98.5% | Diamond |
| Aspergillus oryzae RIB40 | Q2UFN8 | 98.5% | Diamond |
| Bos taurus | F1MNN4 | 96.9% | Diamond |
| Aspergillus fischeri NRRL 181 | A1DHW6 | 95.6% | Diamond |
| Talaromyces stipitatus ATCC 10500 | B8M7Q5 | 90.3% | Diamond |
| Microsporum canis CBS 113480 | C5FP68 | 88.7% | Diamond |
| Drosophila melanogaster | Q9VZF4 | 82.7% | Diamond |
| Aspergillus niger CBS 513.88 | A2QCU8 | 80.8% | Diamond |
| Aspergillus nidulans FGSC A4 | Q00659 | 80.8% | Diamond |
| Aspergillus clavatus NRRL 1 | A1C7E4 | 80.6% | Diamond |
| Aspergillus terreus NIH2624 | Q0CY32 | 80.3% | Diamond |
| Penicillium rubens Wisconsin 54-1255 | B6GZA1 | 68.7% | Diamond |
| Schizosaccharomyces pombe 972h- | P87053 | 54.5% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| CCDC28A | protein-coding | 25901 |
| NHSL1-AS1 | ncRNA | 441172 |
| NHSL1 | protein-coding | 57224 |
| ABRACL | protein-coding | 58527 |
| REPS1 | protein-coding | 85021 |
| TXLNB | protein-coding | 167838 |
| HECA | protein-coding | 51696 |
| CCDC28A-AS1 | ncRNA | 100507462 |
| CITED2 | protein-coding | 10370 |
Protein
Protein identifiers
Epithelial cell-transforming sequence 2 oncogene-like — Q008S8 (reviewed: Q008S8)
Alternative names: Lung-specific F-box and DH domain-containing protein, Putative guanine nucleotide exchange factor LFDH
All UniProt accessions (2): B7ZBI6, Q008S8
UniProt curated annotations — full annotation on UniProt →
Function. May act as a guanine nucleotide exchange factor (GEF).
RefSeq proteins (2): NP_001071174, NP_001181966 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000219 | DH_dom | Domain |
| IPR001810 | F-box_dom | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR025592 | DUF4347 | Domain |
| IPR035899 | DBL_dom_sf | Homologous_superfamily |
| IPR036047 | F-box-like_dom_sf | Homologous_superfamily |
| IPR052805 | ECT2L_FBXO16 | Family |
Pfam: PF00621, PF12937, PF14252
UniProt features (10 total): sequence conflict 4, sequence variant 3, domain 2, chain 1
Structure
Experimental structures (PDB)
1 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 11XU | In situ subtomogram average of the transition zone linker in human airway cilia … | ELECTRON MICROSCOPY | 9.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q008S8-F1 | 74.75 | 0.22 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, UniProt - Evidence at transcript level
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): nucleoplasm; vesicles
Antibody reliability (HPA): IH uncertain · IF approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 30 (showing top):
GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, PAX3_TARGET_GENES, ZNF22_TARGET_GENES, MIR335_3P, MIR3658, MIR4262, MIR561_3P, MIR4766_5P, MIR7154_5P, MIR595, MIR3614_3P, MIR1243
GO Molecular Function (2): guanyl-nucleotide exchange factor activity (GO:0005085), protein binding (GO:0005515)
GO top-level categories
4 GO namespaces:
| Category | Terms |
|---|---|
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
Protein interactions and networks
STRING
showing 15 of 486 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ECT2L | FBXO48 | Q5FWF7 | 551 |
| ECT2L | FBXO47 | Q5MNV8 | 537 |
| ECT2L | CCDC28A | Q8IWP9 | 441 |
| ECT2L | PLEKHG4B | Q96PX9 | 412 |
| ECT2L | ARHGEF19 | Q8IW93 | 386 |
| ECT2L | FGD5 | Q6ZNL6 | 382 |
| ECT2L | FBXL13 | Q8NEE6 | 370 |
| ECT2L | FBXL22 | Q6P050 | 370 |
| ECT2L | LMO7 | Q8WWI1 | 370 |
| ECT2L | FBXL15 | Q9H469 | 360 |
| ECT2L | Q8WV35 | Q8WV35 | 360 |
| ECT2L | FBXL7 | Q9UJT9 | 360 |
| ECT2L | FBXL8 | Q96CD0 | 358 |
| ECT2L | FBXO25 | Q8TCJ0 | 358 |
| ECT2L | FBXO2 | Q9UK22 | 352 |
IntAct
Human interaction partners of ECT2L in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
7 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| GSTM3 | association | 0.530 | 2 |
| HMGA1 | physical association | 0.400 | 1 |
| HNRNPC | physical association | 0.400 | 1 |
| HNRNPCL2 | physical association | 0.400 | 1 |
| KCTD19 | association | 0.350 | 1 |
| NEFL | association | 0.350 | 1 |
| TOMM40 | association | 0.350 | 1 |
BioGRID (33 interactions; top human partners by supporting records): GSTM3 (Affinity Capture-MS; 3 records), SKP1 (Affinity Capture-MS; 2 records), AHNAK2 (Cross-Linking-MS (XL-MS)), CEP76 (Cross-Linking-MS (XL-MS)), CHP1 (Affinity Capture-MS), CTNNA1 (Affinity Capture-MS), DGKZ (Affinity Capture-MS), ESR1 (Affinity Capture-MS), FARSA (Affinity Capture-MS), HAX1 (Affinity Capture-MS), HNRNPCL2 (Cross-Linking-MS (XL-MS)), INA (Affinity Capture-MS), KCTD19 (Affinity Capture-MS), LRRC74A (Affinity Capture-MS), MAGED1 (Affinity Capture-MS)
Disease & clinical
Genetic variants
Variant evidence for ECT2L: 165 ClinVar records (0 pathogenic / likely pathogenic); 1 PharmGKB clinical annotation; 1 GWAS association.
ClinVar
165 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 111 |
| Likely benign | 7 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 34 predictions of 2,739):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 6:138796193–138796194 | donor_loss | 0.9900 | 5 |
| 6:138838496 | donor_gain | 0.9900 | |
| 6:138843232–138843233 | donor_loss | 0.9900 | 5 |
| 6:138849267–138849268 | acceptor_loss | 0.9900 | 6 |
| 6:138849435–138849436 | donor_loss | 0.9900 | 6 |
| 6:138850088 | donor_gain | 0.9900 | |
| 6:138855128 | donor_gain | 0.9900 | |
| 6:138855146 | donor_gain | 0.9900 | |
| 6:138864934 | acceptor_gain | 0.9900 | |
| 6:138868100–138868102 | acceptor_loss | 0.9900 | 7 |
AlphaMissense
1,056 missense substitutions predicted likely pathogenic (of 5,958 scored), across 352 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| D115 | 8 | 0.901 | 0.967 |
| F684 | 8 | 0.864 | 0.960 |
| D733 | 8 | 0.789 | 0.903 |
| W141 | 7 | 0.966 | 0.993 |
| W127 | 7 | 0.938 | 0.990 |
| W118 | 7 | 0.937 | 0.986 |
| W108 | 7 | 0.934 | 0.991 |
| W38 | 7 | 0.928 | 0.989 |
| W374 | 7 | 0.915 | 0.991 |
| W11 | 7 | 0.900 | 0.977 |
| E578 | 7 | 0.897 | 0.964 |
| W457 | 7 | 0.886 | 0.982 |
| F687 | 7 | 0.872 | 0.970 |
| F35 | 7 | 0.869 | 0.961 |
| C122 | 7 | 0.868 | 0.980 |
| F393 | 7 | 0.861 | 0.944 |
| F373 | 7 | 0.853 | 0.957 |
| W34 | 7 | 0.851 | 0.967 |
| F128 | 7 | 0.848 | 0.963 |
| F24 | 7 | 0.842 | 0.942 |
HPA cancer prognostics
RNA cancer specificity: Not detected
Disease associations
OMIM: gene `` | disease phenotypes:
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST003208_5 | Colorectal or endometrial cancer | 4e-7 |
EFO canonical traits (from GWAS)
1 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0004230 | endometrial neoplasm |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
PharmGKB clinical annotations
1 annotations by evidence level (1 strongest → 4):
| Variant | Association | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs11155012 | Efficacy | 3 | anthracyclines and related substances | Breast Neoplasms |
PharmGKB variants
1 variants:
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs11155012 | ECT2L | 3 | 1.75 | 1 | anthracyclines and related substances |
PharmGKB variant annotations
Per-publication pharmacogenomic findings for this gene (significant associations).
1 published findings:
| Variant | Drug(s) | Category | Finding | PMID |
|---|---|---|---|---|
| rs11155012 | anthracyclines and related substances | Efficacy | Allele A is associated with increased risk of Death when treated with anthracyclines and related substances in women with Breast Neoplasms as compared to allele G. | PMID:25823661 |
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| 2,6-dichloro-(1,4)benzoquinone | increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.